5 amino 1mq pharmacogenetics snp rsid 5-Amino-1MQ (5mg & 50mg) for Research 5-Amino-1MQ | peptide+

The FDA recently banned AOD 9604 from compounding due to safety concerns and lack of approval for medical use

[DOI] [PubMed] [Google Scholar] 53.Coll AP, Loraine Tung YC

It is used in the treatment of neurological conditions caused due to vitamin B1, vitamin B6 and vitamin B12 deficiency

While cyanocobalamin can still raise blood levels, it may not act as quickly or effectively in neurological tissue

For additional safety information, please see Full Prescribing Information

Maximus uses an MCT-oil base that's smooth, less viscous, and designed for reliable absorption and comfortable injections with lower risk of inflammation